Dissertation

TENOFOVIR DISOPROXIL FUMARATE RELEASE FROM GLUTARALDEHYDE CROSS-LINKED CHITOSAN/Β-CYCLODEXTRIN HYDROGEL

Volume: 52 Number: 2 April 1, 2024
EN

TENOFOVIR DISOPROXIL FUMARATE RELEASE FROM GLUTARALDEHYDE CROSS-LINKED CHITOSAN/Β-CYCLODEXTRIN HYDROGEL

Abstract

In this study, chitosan was produced from crayfish Astacus leptodactylus, and then it was used to synthesize chitosan-graft-β-cyclodextrin (CS-g-β-CD) hydrogel. The produced chitosan (CS) and the sythesized CS-g-β-CD hydrogel were characterized using a Fourier Transform Infrared Spectroscopy (FTIR), Proton Nuclear Magnetic Resonance Spectroscopy (1H-NMR), X-ray Diffraction (XRD), and Scanning Electron Microscopy (SEM). Tenofovir disoproxil fumarate (TDF) was used as a model to investigate the antiviral drug release properties of the CS-g-β-CD hydrogel. The synthesized hydrogel had an almost homogeneous pore structure and a high swelling capacity which increases depending on the amount of β-Cyclodextrin (β-CD). The drug-loaded CS-g-β-CD hydrogels was examined by XRD and 1H-NMR, and SEM analyses. Seventy-three percent of the TDF loaded on the synthesized hydrogels was released into phosphate-buffered saline (PBS) solution at 37 ºC. The drug release behavior of all prepared CS-g-β-CD hydrogels fitted the Korsmeyer-Peppas model. The addition of β-CD into the gel improved the swelling ability and TDF release of the CS-g-β-CD hydrogel system.

Keywords

Supporting Institution

Trakya University Scientific Research Projects Unit

Project Number

TUBAP 2020/149

Thanks

The authors thank Nobel İlaç San. ve Tic. A.Ş. (Turkey) for their contribution to supply the active substance Tenofovir disoproxil fumarate.

References

  1. WHO, 2021a. “World Health Organisation, Coronavirus (COVID-19)”, https://covid19.who.int/ (Erişim tarihi: 29.10.2021)
  2. K. Kurt, L. Dönbak, A. Kayraldız, Tenofovir Disoproxil Fumarate in the Treatment of AIDS, Archives Medical Review Journal, 24 (2015) 119-134.
  3. WHO, 2021b. “World Health Organisation, Hepatitis B”, https://www.who.int/news-room/fact-sheets/detail/hepatitis-b (Erişim tarihi: 29.10.2021)
  4. UNAIDS, 2021. “The Joint United Nations Programme on HIV/AIDS, Global HIV & AIDS statistics-Fact sheet”, https://www.unaids.org/en/resources/fact-sheet (Erişim tarihi: 02.12.2021)
  5. D. Yu, J. Heathcote, Tenofovir in the treatment of chronic hepatitis B, Therapy, 8 (2011) 527-544.
  6. J.E. Gallant, S. Deresinski, Tenofovir disoproxil fumarate, Clin. Infect. Dis., 37 (2003) 944-950.
  7. S.M. Ecin, N. Çalık Başaran, M. Aladağ, Evaluation of the Effectiveness of Tenofovir in Chronic Hepatitis B Patients, Acta Medica, 51 (2020) 9-14.
  8. J. Li, D.H. Zhang, X.X. Zhang, The Occurrence of rtA194T Mutant After Long-Term Lamivudine Monotherapy Remains Sensitive to Tenofovir Disoproxil Fumarate: A Case Report, Infect. Drug Resist., 14 (2021) 1013-1017.

Details

Primary Language

English

Subjects

Macromolecular Materials, Characterisation of Biological Macromolecules

Journal Section

Dissertation

Publication Date

April 1, 2024

Submission Date

August 2, 2023

Acceptance Date

December 9, 2023

Published in Issue

Year 2024 Volume: 52 Number: 2

APA
Yaman, N., Erdogan, S., & Taşdelen, B. (2024). TENOFOVIR DISOPROXIL FUMARATE RELEASE FROM GLUTARALDEHYDE CROSS-LINKED CHITOSAN/Β-CYCLODEXTRIN HYDROGEL. Hacettepe Journal of Biology and Chemistry, 52(2), 97-115. https://doi.org/10.15671/hjbc.1335348
AMA
1.Yaman N, Erdogan S, Taşdelen B. TENOFOVIR DISOPROXIL FUMARATE RELEASE FROM GLUTARALDEHYDE CROSS-LINKED CHITOSAN/Β-CYCLODEXTRIN HYDROGEL. HJBC. 2024;52(2):97-115. doi:10.15671/hjbc.1335348
Chicago
Yaman, Nuh, Sevil Erdogan, and Betül Taşdelen. 2024. “TENOFOVIR DISOPROXIL FUMARATE RELEASE FROM GLUTARALDEHYDE CROSS-LINKED CHITOSAN Β-CYCLODEXTRIN HYDROGEL”. Hacettepe Journal of Biology and Chemistry 52 (2): 97-115. https://doi.org/10.15671/hjbc.1335348.
EndNote
Yaman N, Erdogan S, Taşdelen B (April 1, 2024) TENOFOVIR DISOPROXIL FUMARATE RELEASE FROM GLUTARALDEHYDE CROSS-LINKED CHITOSAN/Β-CYCLODEXTRIN HYDROGEL. Hacettepe Journal of Biology and Chemistry 52 2 97–115.
IEEE
[1]N. Yaman, S. Erdogan, and B. Taşdelen, “TENOFOVIR DISOPROXIL FUMARATE RELEASE FROM GLUTARALDEHYDE CROSS-LINKED CHITOSAN/Β-CYCLODEXTRIN HYDROGEL”, HJBC, vol. 52, no. 2, pp. 97–115, Apr. 2024, doi: 10.15671/hjbc.1335348.
ISNAD
Yaman, Nuh - Erdogan, Sevil - Taşdelen, Betül. “TENOFOVIR DISOPROXIL FUMARATE RELEASE FROM GLUTARALDEHYDE CROSS-LINKED CHITOSAN Β-CYCLODEXTRIN HYDROGEL”. Hacettepe Journal of Biology and Chemistry 52/2 (April 1, 2024): 97-115. https://doi.org/10.15671/hjbc.1335348.
JAMA
1.Yaman N, Erdogan S, Taşdelen B. TENOFOVIR DISOPROXIL FUMARATE RELEASE FROM GLUTARALDEHYDE CROSS-LINKED CHITOSAN/Β-CYCLODEXTRIN HYDROGEL. HJBC. 2024;52:97–115.
MLA
Yaman, Nuh, et al. “TENOFOVIR DISOPROXIL FUMARATE RELEASE FROM GLUTARALDEHYDE CROSS-LINKED CHITOSAN Β-CYCLODEXTRIN HYDROGEL”. Hacettepe Journal of Biology and Chemistry, vol. 52, no. 2, Apr. 2024, pp. 97-115, doi:10.15671/hjbc.1335348.
Vancouver
1.Nuh Yaman, Sevil Erdogan, Betül Taşdelen. TENOFOVIR DISOPROXIL FUMARATE RELEASE FROM GLUTARALDEHYDE CROSS-LINKED CHITOSAN/Β-CYCLODEXTRIN HYDROGEL. HJBC. 2024 Apr. 1;52(2):97-115. doi:10.15671/hjbc.1335348

HACETTEPE JOURNAL OF BIOLOGY AND CHEMİSTRY

Copyright © Hacettepe University Faculty of Science

http://www.hjbc.hacettepe.edu.tr/

https://dergipark.org.tr/tr/pub/hjbc